FDA Commissioner Marty Makary, M.D., M.P.H., characterized the program as a “bold step” to bring manufacturing back to the US and make the domestic sector more resilient and competitive. This program ...

Kiriayani Diaz remembers wanting to be a pediatrician when she was growing up. But as high school graduation approached in early 2021, she was undecided about which career path she wanted to take, and ...

As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...

SanegeneBio and Genentech entered a global licensing agreement aimed at advancing an RNA interference (RNAi) therapeutic ...

Feb 12 (Reuters) - A federal judge on Monday dismissed a lawsuit by a major pharmaceutical industry trade association challenging a new program that allows Medicare to negotiate prices with drug ...

AUGUSTA, Maine (WABI) - Members of The Coalition to Protect Health Care for Rural and Underserved Communities met at the State House Wednesday to ask lawmakers to support a bill they say will protect ...

RESEARCH TRIANGLE PARK, N.C., March 6, 2025 /PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today ...

The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced ...

Over the past year, Democrats in Washington have begun to level the playing field between healthcare special interests like Big Pharma manufacturers and regular Americans, especially those most in ...